Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06527872
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-26
Brief Title:
Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Evaluation Of Use of Belimumab in Routine Care SEttings in Lupus Nephritis LN the OBSErve-LN Study
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
OBSErve-LN
Brief Summary:
The purpose of the OBSErve-LN study is to assess the real-world use and effectiveness of belimumab in routine practice for the treatment of adults with active LN in multiple countries of interest This study aims to provide the first long-term up to 5 years assessment of renal function preservation in belimumab treated participants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None